(Q51621473)

8 April 2018

title

Principles and analytical performance of Abbott RealTime High Risk HPV test. (English)

1 reference

8 April 2018

author name string

Shihai Huang

1

1 reference

8 April 2018

Ning Tang

2

1 reference

8 April 2018

Wai-Bing Mak

3

1 reference

8 April 2018

Brian Erickson

4

1 reference

8 April 2018

John Salituro

5

1 reference

8 April 2018

Yuhong Li

6

1 reference

8 April 2018

Evelyn Krumpe

7

1 reference

8 April 2018

George Schneider

8

1 reference

8 April 2018

Hong Yu

9

1 reference

8 April 2018

John Robinson

10

1 reference

8 April 2018

Klara Abravaya

11

1 reference

8 April 2018

publication date

1 July 2009

1 reference

8 April 2018

Journal of Clinical Virology

published in

1 reference

8 April 2018

volume

45 Suppl 1

1 reference

8 April 2018

page(s)

S13-7

1 reference

8 April 2018

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970003-4

7 January 2021

The causal relation between human papillomavirus and cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970003-4

7 January 2021

Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970003-4

7 January 2021

The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970003-4

7 January 2021

Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970003-4

7 January 2021

Cervical cancer screening following prophylactic human papillomavirus vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970003-4

7 January 2021

Monitoring HPV vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970003-4

7 January 2021

A new method for robust quantitative and qualitative analysis of real-time PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970003-4

7 January 2021

Clinical performance of Abbott RealTime High Risk HPV test for detection of high-grade cervical intraepithelial neoplasia in women with abnormal cytology

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970003-4

7 January 2021

High-risk HPV detection and concurrent HPV 16 and 18 typing with Abbott RealTime High Risk HPV test

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970003-4

7 January 2021

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970003-4

7 January 2021

Clinical utility of HPV genotyping

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970003-4

7 January 2021

HPV detection methods

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970003-4

7 January 2021

10.1016/S1386-6532(09)70003-4

Identifiers

DOI

1 reference

8 April 2018

1 reference

8 April 2018